Search
DaVita Inc
DVAAdd to Watchlist
198.650USD
+2.390+1.22%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
12.75BMarket Cap
18.16P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.22%
5 Days
+30.99%
1 Month
+33.83%
6 Months
+60.60%
Year to Date
+74.85%
1 Year
+38.31%
TradingKey Stock Score of DaVita Inc
Currency: USD Updated: 2026-05-08Key Insights
DaVita Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 151.51.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
DaVita Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
DaVita Inc Highlights
StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Overvalued
The company’s latest PE is 18.16, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 35.22M shares, decreasing 11.28% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 595.00 shares of this stock.
Analyst Rating
Based on
10
analysts
Hold
Current Rating
151.514
Target Price
-1.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
DaVita Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
DaVita Inc Info
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Ticker SymbolDVA
CompanyDaVita Inc
CEORodriguez (Javier J)
Websitehttps://www.davita.com/
Related Instruments
+2.77%
-1.99%
-0.76%
-3.09%
-2.56%
+3.65%
-2.98%
-2.32%
+1.44%
+1.38%
-4.67%
+1.42%
-5.59%
+2.12%
-3.38%
-2.11%
-2.50%
+1.32%
+11.27%
-2.55%Popular Instruments
92.193
-2.977 (-3.13%)
293.320
+5.880 (+2.05%)
215.200
+3.700 (+1.75%)
4714.280
+29.030 (+0.62%)
480.000
+16.090 (+3.47%)
1562.340
+222.380 (+16.60%)
746.810
+100.180 (+15.49%)
400.800
+2.810 (+0.71%)
80802.450
+699.360 (+0.87%)
428.350
+16.560 (+4.02%)
